
Innogen grants Arcera exclusive rights to its long-acting GLP-1 receptor agonist across Africa, Eastern Europe, Latin America and the Middle East.
almost 4 years ago
2023 Pipeline Report: Testing the Limitsalmost 4 years ago
Business and Passionalmost 4 years ago
Back in Person, Sparks Could Fly at Upcoming J.P. Morgan Conferencealmost 4 years ago
Aligning Trust and Transparency in Brand Messagingalmost 4 years ago
Pharma Needs to Look Internally for New Leadershipalmost 4 years ago
Seeking Concrete Solutions to Europe’s Supply Problemsalmost 4 years ago
Pandemic and Politics Shaped Pharma and FDA in 2022almost 4 years ago
Medical Affairs Uptickabout 4 years ago
Virtual Medical Affairs Audits: A Viable Alternative




